Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Weighty Matters: Physical Therapy and GLP-1 Medications

Aug 1, 2025/Feature

What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.

Defining Moment: The Path Chose Me

Jun 1, 2024/Column

A PT finds meaning and purpose helping other cancer survivors.

On the Right Track

May 1, 2023/Feature

How PTs can help with the unique challenges race car drivers face.

On the Pathway to Greatness

Apr 1, 2023/Feature

APTA's PTA Advanced Proficiency Pathways program provides skills and recognition for physical therapist assistants.

APTA Centennial Scholars Spotlight: April 2022

Apr 1, 2022/Feature

This month, APTA Magazine spotlights the following APTA Centennial Scholars: LaDonna Dingle, Emily Quinn, Zachary Walston, and Cara N. Whalen Smith.

Mini-Cog

Jun 28, 2017/Test & Measure

Used during systems review to identify cognitive impairment in various patient populations.

Education Leadership Partnership Looks Back On a Productive Year

Mar 6, 2019/News

When the purpose of a group is nothing less than "partnering to drive excellence in physical therapy education," you have every reason to expect that group to be doing, well…a lot of stuff. The 2018 annual report of the entities collectively known as the Education Leadership Partnership (ELP)—APTA, the

CMS Makes Changes to DMEPOS Prior Approval, Other Restriction Lists

Jan 21, 2022/News

The changes, many of which could affect PTs, will begin April 13. Now's the time to prepare.

Congress Introduces APTA-Supported Bill to Increase Payment Under 2025 Medicare Fee Schedule

Oct 29, 2024/News

In anticipation of the 2025 fee schedule final rule, a new bipartisan bill would change an expected 2.8% cut to a 1.9% increase.

Reference Committee

Aug 1, 2025/Open Access

The Reference Committee is appointed by the APTA Board of Directors. The detailed charge outlining the roles and responsibilities of this committee is provided below.